Menu Back to Course-2-ICH-Clinical-Safety-and-Efficacy

Overview

Short Course* Registration: 8:00AM-4:30PM


The International Council for Harmonisation (ICH) of Technical Requirements for Pharmaceuticals for Human Use is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of drug registration. Since its inception in 1990, ICH has gradually evolved to respond to the increasingly global face of drug development. ICH's mission is to achieve greater harmonization worldwide to ensure that safe, effective, and high-quality medicines are developed and registered in the most resource-efficient manner.
Harmonization is achieved through the development of ICH Guidelines via a process of scientific consensus with regulatory and industry experts working side-by-side. The key to the success of this process is the commitment of the ICH regulators to implement the final Guidelines.

This introductory training course will provide an overview of the ICH process, the value that ICH brings to drug regulation in Canada, as well as ICH clinical safety and efficacy guidelines.


Featured Topics

  • ICH Introduction
  • E9: Addendum to Defining Appropriate Estimand for a Clinical Trial/Sensitivity Analyses
  • E11: Addendum to Paediatric Drug Development
  • E17: Multi-Regional Clinical Trials
  • E15, E16, and E18: Pharmacogenomics
  • S9: Nonclinical Evaluation for Anticancer Pharmaceuticals
  • M7: Assessment and Control of DNA Reactive Impurities

*Short Courses are not included in the conference registration and require a separate fee.

Return to DIA Annual Canadian Meeting

What you will learn

At the conclusion of this short course, participants should be able to:

  • Understand the ICH process and how ICH guidelines are developed and implemented in Canada
  • Recognize the value that ICH brings to drug regulation in Canada
  • Describe and understand key ICH quality guidelines
  • Recognize how and when to use the guidelines throughout the life cycle of a drug product

Who should attend?

Professionals involved in:

  • Drug safety
  • Pharmacoepidemiology
  • Regulatory affairs
  • Clinical development/clinical sciences
  • Project management

Contact us

Customer Service

1.888.257.6457


Short Course 1

Quality Stream


Return to

DIA Annual Canadian Meeting